Literature DB >> 27278366

Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs.

Elif Tekin1, Casey Beppler2, Cynthia White2, Zhiyuan Mao2, Van M Savage3, Pamela J Yeh4.   

Abstract

Interactions among drugs play a critical role in the killing efficacy of multi-drug treatments. Recent advances in theory and experiment for three-drug interactions enable the search for emergent interactions-ones not predictable from pairwise interactions. Previous work has shown it is easier to detect synergies and antagonisms among pairwise interactions when a rescaling method is applied to the interaction metric. However, no study has carefully examined whether new types of normalization might be needed for emergence. Here, we propose several rescaling methods for enhancing the classification of the higher order drug interactions based on our conceptual framework. To choose the rescaling that best separates synergism, antagonism and additivity, we conducted bacterial growth experiments in the presence of single, pairwise and triple-drug combinations among 14 antibiotics. We found one of our rescaling methods is far better at distinguishing synergistic and antagonistic emergent interactions than any of the other methods. Using our new method, we find around 50% of emergent interactions are additive, much less than previous reports of greater than 90% additivity. We conclude that higher order emergent interactions are much more common than previously believed, and we argue these findings for drugs suggest that appropriate rescaling is crucial to infer higher order interactions.
© 2016 The Author(s).

Keywords:  antibiotics; drug resistance; higher order interactions

Mesh:

Substances:

Year:  2016        PMID: 27278366      PMCID: PMC4938094          DOI: 10.1098/rsif.2016.0332

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  45 in total

1.  Functional classification of drugs by properties of their pairwise interactions.

Authors:  Pamela Yeh; Ariane I Tschumi; Roy Kishony
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

Review 2.  Antibiotic adjuvants: multicomponent anti-infective strategies.

Authors:  Lindsay Kalan; Gerard D Wright
Journal:  Expert Rev Mol Med       Date:  2011-02-23       Impact factor: 5.600

3.  Protein evolution. Pervasive degeneracy and epistasis in a protein-protein interface.

Authors:  Anna I Podgornaia; Michael T Laub
Journal:  Science       Date:  2015-02-06       Impact factor: 47.728

4.  Modular epistasis in yeast metabolism.

Authors:  Daniel Segrè; Alexander Deluna; George M Church; Roy Kishony
Journal:  Nat Genet       Date:  2004-12-12       Impact factor: 38.330

5.  Epistatic interactions among metabolic genes depend upon environmental conditions.

Authors:  Chintan Jagdishchandra Joshi; Ashok Prasad
Journal:  Mol Biosyst       Date:  2014-10

6.  Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Stephanie Lustgarten; Kathleen E Squires; William A Meyer; Edward P Acosta; Bruce R Schackman; Christopher D Pilcher; Robert L Murphy; William E Maher; Mallory D Witt; Richard C Reichman; Sally Snyder; Karin L Klingman; Daniel R Kuritzkes
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.

Authors:  Razan Hamoud; Stefan Zimmermann; Jürgen Reichling; Michael Wink
Journal:  Phytomedicine       Date:  2013-11-18       Impact factor: 5.340

8.  Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production.

Authors:  Mark P Brynildsen; Jonathan A Winkler; Catherine S Spina; I Cody MacDonald; James J Collins
Journal:  Nat Biotechnol       Date:  2013-01-06       Impact factor: 54.908

9.  Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks.

Authors:  Xionglei He; Wenfeng Qian; Zhi Wang; Ying Li; Jianzhi Zhang
Journal:  Nat Genet       Date:  2010-01-24       Impact factor: 38.330

10.  Bacterial evolution of antibiotic hypersensitivity.

Authors:  Viktória Lázár; Gajinder Pal Singh; Réka Spohn; István Nagy; Balázs Horváth; Mónika Hrtyan; Róbert Busa-Fekete; Balázs Bogos; Orsolya Méhi; Bálint Csörgő; György Pósfai; Gergely Fekete; Balázs Szappanos; Balázs Kégl; Balázs Papp; Csaba Pál
Journal:  Mol Syst Biol       Date:  2013-10-29       Impact factor: 11.429

View more
  18 in total

Review 1.  Suppressive drug combinations and their potential to combat antibiotic resistance.

Authors:  Nina Singh; Pamela J Yeh
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

2.  Diagonal Method to Measure Synergy Among Any Number of Drugs.

Authors:  Melike Cokol-Cakmak; Feray Bakan; Selim Cetiner; Murat Cokol
Journal:  J Vis Exp       Date:  2018-06-21       Impact factor: 1.355

3.  Pattern Discovery from High-Order Drug-Drug Interaction Relations.

Authors:  Wen-Hao Chiang; Titus Schleyer; Li Shen; Lang Li; Xia Ning
Journal:  J Healthc Inform Res       Date:  2018-06-18

4.  The context-dependent, combinatorial logic of BMP signaling.

Authors:  Heidi E Klumpe; Matthew A Langley; James M Linton; Christina J Su; Yaron E Antebi; Michael B Elowitz
Journal:  Cell Syst       Date:  2022-04-13       Impact factor: 11.091

5.  Price equation captures the role of drug interactions and collateral effects in the evolution of multidrug resistance.

Authors:  Erida Gjini; Kevin B Wood
Journal:  Elife       Date:  2021-07-22       Impact factor: 8.140

6.  Uncovering emergent interactions in three-way combinations of stressors.

Authors:  Casey Beppler; Elif Tekin; Zhiyuan Mao; Cynthia White; Cassandra McDiarmid; Emily Vargas; Jeffrey H Miller; Van M Savage; Pamela J Yeh
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.293

7.  When more is less: Emergent suppressive interactions in three-drug combinations.

Authors:  Casey Beppler; Elif Tekin; Cynthia White; Zhiyuan Mao; Jeffrey H Miller; Robert Damoiseaux; Van M Savage; Pamela J Yeh
Journal:  BMC Microbiol       Date:  2017-05-06       Impact factor: 3.605

8.  Antibiotic resistance: Alternative approaches.

Authors:  Rajneesh Kumar Gaur
Journal:  Indian J Pharmacol       Date:  2017 Mar-Apr       Impact factor: 1.200

9.  COMBSecretomics: A pragmatic methodological framework for higher-order drug combination analysis using secretomics.

Authors:  Efthymia Chantzi; Michael Neidlin; George A Macheras; Leonidas G Alexopoulos; Mats G Gustafsson
Journal:  PLoS One       Date:  2020-05-14       Impact factor: 3.240

10.  A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.

Authors:  Sebastian G Wicha; Chunli Chen; Oskar Clewe; Ulrika S H Simonsson
Journal:  Nat Commun       Date:  2017-12-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.